Suppr超能文献

N-甲基-D-天冬氨酸受体介导的兴奋性突触后电位及突触可塑性对大鼠海马脑片TCN 201和TCN 213的敏感性

Sensitivity of N-methyl-D-aspartate receptor-mediated excitatory postsynaptic potentials and synaptic plasticity to TCN 201 and TCN 213 in rat hippocampal slices.

作者信息

Izumi Yukitoshi, Zorumski Charles F

机构信息

Department of Psychiatry and Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine, St. Louis, Missouri

Department of Psychiatry and Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine, St. Louis, Missouri.

出版信息

J Pharmacol Exp Ther. 2015 Feb;352(2):267-73. doi: 10.1124/jpet.114.220582. Epub 2014 Nov 20.

Abstract

Whereas ifenprodil has been used as a selective GluN1/GluN2B (NR1/NR2B, B-type) receptor antagonist to distinguish between GluN2B (NR2B) and GluN2A (NR2A)-containing N-methyl-d-aspartate receptors (NMDARs), TCN 201 (3-chloro-4-fluoro-N-[4-[[2-(phenylcarbonyl)hydrazino]carbonyl]benzyl]benzenesulphonamide) and TCN 213 [N-(cyclohexylmethyl)-2-[{5-[(phenylmethyl)amino]-1,3,4-thiadiazol-2-yl}thio]acetamide] have been found to be selective GluN1/GluN2A (NR1/NR2A, A-type) antagonists. Based on the premise that A- and B-types are major synaptic NMDARs, we examined whether inhibition of NMDAR excitatory postsynaptic potentials (EPSPs) by the TCN compounds and ifenprodil are complementary. Contrary to this prediction, inhibition of NMDAR EPSPs by the TCN compounds and ifenprodil were largely overlapping in the CA1 region of hippocampal slices from 30-day-old rats. After partial inhibition by ifenprodil, TCN compounds produced little further suppression of NMDAR EPSPs. Similarly, after partial inhibition by TCN compounds ifenprodil failed to further suppress NMDAR EPSPs. However, low micromolar d-2-amino-5-phosphonovalerate, a competitive NMDAR antagonist, which alone only partially inhibits NMDAR EPSPs, markedly suppresses residual NMDAR responses in the presence of ifenprodil or the TCNs, suggesting that low 2-amino-5-phosphonovalerate antagonizes both ifenprodil- and TCN-insensitive synaptic NMDARs. These observations can be most readily interpreted if ifenprodil and TCNs act on a similar population of synaptic NMDARs. Recent lines of evidence suggest that the majority of hippocampal synaptic NMDARs are triheteromers. If so, modulation of GluN2A, and not just GluN2B NMDARs, could dampen long-term depression (LTD). Indeed, both TCNs, like ifenprodil, blocked LTD, suggesting the involvement of ifenprodil- and TCN-sensitive NMDARs in LTD induction. However, the TCNs plus ifenprodil failed to inhibit long-term potentiation (LTP), suggesting that neither ifenprodil- nor TCN-sensitive NMDARs are essential for LTP induction.

摘要

而异环磷酰胺已被用作选择性GluN1/GluN2B(NR1/NR2B,B型)受体拮抗剂,以区分含GluN2B(NR2B)和含GluN2A(NR2A)的N-甲基-D-天冬氨酸受体(NMDARs),已发现TCN 201(3-氯-4-氟-N-[4-[[2-(苯基羰基)肼基]羰基]苄基]苯磺酰胺)和TCN 213 [N-(环己基甲基)-2-[{5-[(苄基氨基]-1,3,4-噻二唑-2-基}硫代]乙酰胺]是选择性GluN1/GluN2A(NR1/NR2A,A型)拮抗剂。基于A型和B型是主要突触NMDARs这一前提,我们研究了TCN化合物和异环磷酰胺对NMDAR兴奋性突触后电位(EPSPs)的抑制作用是否互补。与这一预测相反,在30日龄大鼠海马切片的CA1区,TCN化合物和异环磷酰胺对NMDAR EPSPs的抑制作用在很大程度上是重叠的。在异环磷酰胺部分抑制后,TCN化合物对NMDAR EPSPs几乎没有进一步的抑制作用。同样,在TCN化合物部分抑制后,异环磷酰胺也未能进一步抑制NMDAR EPSPs。然而,低微摩尔浓度的D-2-氨基-5-磷酸戊酸,一种竞争性NMDAR拮抗剂,单独使用时仅部分抑制NMDAR EPSPs,在存在异环磷酰胺或TCN时能显著抑制残余的NMDAR反应,这表明低浓度的2-氨基-5-磷酸戊酸能拮抗异环磷酰胺和TCN不敏感的突触NMDARs。如果异环磷酰胺和TCN作用于相似群体的突触NMDARs,这些观察结果最容易得到解释。最近的一系列证据表明,大多数海马突触NMDARs是三杂聚体。如果是这样,调节GluN2A,而不仅仅是GluN2B NMDARs,可能会抑制长时程抑制(LTD)。事实上,与异环磷酰胺一样,两种TCN都能阻断LTD,这表明异环磷酰胺和TCN敏感的NMDARs参与了LTD的诱导。然而,TCN加异环磷酰胺未能抑制长时程增强(LTP),这表明异环磷酰胺和TCN敏感的NMDARs对LTP的诱导都不是必需的。

相似文献

2
Zinc modulates bidirectional hippocampal plasticity by effects on NMDA receptors.
J Neurosci. 2006 Jul 5;26(27):7181-8. doi: 10.1523/JNEUROSCI.1258-06.2006.
3
TCN 201 selectively blocks GluN2A-containing NMDARs in a GluN1 co-agonist dependent but non-competitive manner.
Neuropharmacology. 2012 Sep;63(3):441-9. doi: 10.1016/j.neuropharm.2012.04.027. Epub 2012 May 1.
7
NR2A-containing NMDA receptors are required for LTP induction in rat dorsolateral striatum in vitro.
Brain Res. 2009 Jun 5;1274:40-6. doi: 10.1016/j.brainres.2009.04.016. Epub 2009 Apr 17.
8
Metaplastic effects of subanesthetic ketamine on CA1 hippocampal function.
Neuropharmacology. 2014 Nov;86:273-81. doi: 10.1016/j.neuropharm.2014.08.002. Epub 2014 Aug 13.
9
Hippocampal long-term synaptic plasticity and signal amplification of NMDA receptors.
Crit Rev Neurobiol. 2006;18(1-2):71-84. doi: 10.1615/critrevneurobiol.v18.i1-2.80.

引用本文的文献

1
Lack of Pannexin 1 Alters Synaptic GluN2 Subunit Composition and Spatial Reversal Learning in Mice.
Front Mol Neurosci. 2018 Apr 10;11:114. doi: 10.3389/fnmol.2018.00114. eCollection 2018.
2
Triheteromeric NMDA receptors: from structure to synaptic physiology.
Curr Opin Physiol. 2018 Apr;2:1-12. doi: 10.1016/j.cophys.2017.12.004. Epub 2017 Dec 19.
3
Long-Term Depression Is Independent of GluN2 Subunit Composition.
J Neurosci. 2018 May 9;38(19):4462-4470. doi: 10.1523/JNEUROSCI.0394-18.2018. Epub 2018 Mar 28.
5
NMDA Receptors in the Central Nervous System.
Methods Mol Biol. 2017;1677:1-80. doi: 10.1007/978-1-4939-7321-7_1.
6
Nampt is required for long-term depression and the function of GluN2B subunit-containing NMDA receptors.
Brain Res Bull. 2015 Oct;119(Pt A):41-51. doi: 10.1016/j.brainresbull.2015.10.005. Epub 2015 Oct 19.

本文引用的文献

1
Distinct functional and pharmacological properties of Triheteromeric GluN1/GluN2A/GluN2B NMDA receptors.
Neuron. 2014 Mar 5;81(5):1084-1096. doi: 10.1016/j.neuron.2014.01.035.
2
GluN2A and GluN2B subunit-containing NMDA receptors in hippocampal plasticity.
Philos Trans R Soc Lond B Biol Sci. 2013 Dec 2;369(1633):20130163. doi: 10.1098/rstb.2013.0163. Print 2014 Jan 5.
3
Triheteromeric NMDA receptors at hippocampal synapses.
J Neurosci. 2013 May 22;33(21):9150-60. doi: 10.1523/JNEUROSCI.0829-13.2013.
4
6
TCN 201 selectively blocks GluN2A-containing NMDARs in a GluN1 co-agonist dependent but non-competitive manner.
Neuropharmacology. 2012 Sep;63(3):441-9. doi: 10.1016/j.neuropharm.2012.04.027. Epub 2012 May 1.
7
Subunit-selective allosteric inhibition of glycine binding to NMDA receptors.
J Neurosci. 2012 May 2;32(18):6197-208. doi: 10.1523/JNEUROSCI.5757-11.2012.
8
Glycine reuptake inhibitor RG1678: a pharmacologic characterization of an investigational agent for the treatment of schizophrenia.
Neuropharmacology. 2012 Feb;62(2):1152-61. doi: 10.1016/j.neuropharm.2011.11.008. Epub 2011 Nov 27.
9
NMDA receptors, mGluR5, and endocannabinoids are involved in a cascade leading to hippocampal long-term depression.
Neuropsychopharmacology. 2012 Feb;37(3):609-17. doi: 10.1038/npp.2011.243. Epub 2011 Oct 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验